What clinical trials are currently recruiting in Georgia?

TrialFinder lists 2107 recruiting clinical trials with sites in or near Georgia. Results cover a wide range of conditions and are updated regularly from ClinicalTrials.gov.

Do I need insurance to join a clinical trial in Georgia?

No. Study-related care is covered by the trial sponsor at no cost to participants. This includes the experimental treatment, required lab tests, and study visits. Many trials also provide compensation for time and travel. Health insurance is not required to search or enroll.

What conditions have clinical trials recruiting in Georgia?

Trials in Georgia cover a broad range of conditions including cancer, diabetes, heart disease, neurological disorders, autoimmune diseases, mental health conditions, and more. Use TrialFinder to search by specific condition and location.

How do I sign up for a clinical trial in Georgia?

Find a trial that matches your condition on TrialFinder, review the eligibility criteria, and contact the research site listed on the trial detail page. Most research teams will conduct a brief phone pre-screening before any in-person visit. You can also create a free TrialFinder profile to get matched to recruiting trials near you.

2107 Recruiting Trials

Clinical Trials
in Georgia

Browse 2107 recruiting clinical trials currently enrolling participants in Georgia. Search by condition to find trials you may qualify for, at no cost.

Showing 15 of 2107 recruiting trials in Georgia

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

PHASE3 Birmingham, Alabama +4 sites · Low Grade Glioma, Low Grade Astrocytoma

Recruiting

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

PHASE1 Duarte, California +4 sites · Melanoma, Head and Neck Cancer

Recruiting

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

NA Birmingham, Alabama +4 sites · Ovarian Carcinoma

Recruiting

Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System

N/A Long Beach, California +4 sites · Pulmonary Embolism

Recruiting

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

N/A Anchorage, Alaska +4 sites · Malignant Solid Neoplasm

Recruiting

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

PHASE1 Orange, California +4 sites · Locally Advanced Solid Tumor, Metastatic Solid Tumor

Recruiting

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

PHASE1 Phoenix, Arizona +4 sites · Recurrent Glioblastoma, IDH-Wildtype, MGMT-Methylated Glioblastoma

Recruiting

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

PHASE2 Birmingham, Alabama +4 sites · Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy

Recruiting

A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

NA Los Angeles, California +4 sites · Acute Lymphoblastic Leukemia, B-All

Recruiting

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

PHASE3 Washington D.C., District of Columbia +4 sites · Stage I Uterine Corpus Cancer AJCC v8, Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8

Recruiting

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

PHASE2 Phoenix, Arizona +4 sites · Muscle Invasive Bladder Urothelial Carcinoma, Stage IV Bladder Urothelial Carcinoma AJCC v7

Recruiting

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

PHASE2 Dublin, California +4 sites · Recurrent Nasopharyngeal Carcinoma, Metastatic Nasopharyngeal Carcinoma

Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

PHASE3 Birmingham, Alabama +4 sites · Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8

Recruiting

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

PHASE3 Birmingham, Alabama +4 sites · NASH With Fibrosis, MASH With Fibrosis

Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

PHASE3 Chandler, Arizona +4 sites · Melanoma

Recruiting

See all 2107 results in Georgia

Check Your Eligibility

Create a free profile and our AI will match you to trials in Georgia you may qualify for.

Get Matched — Free

No insurance required

Search by Condition in Georgia

Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19

Browse Other States

California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon

Clinical Trialsin Georgia

Showing 15 of 2107 recruiting trials in Georgia

Check Your Eligibility

Clinical Trials
in Georgia